These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33835011)

  • 21. Peritoneal Dialysis Exit-Site Care Protocols in Portugal and Its Association with Catheter-Related Infections.
    Ferreira AC; Fernandes V; Rodrigues A; Abreu CP; Pereira M; Guedes AM; Gomes AM; Cabrita A; Soares C; Pego C; Ferrer F; Bernardo I; Fernandes JC; Assunção J; Oliveira L; Amoedo M; Carvalho MJ; Branco P; Maia P; Chorão R; Castro R; Silva R; Sousa T; Mendes T;
    Blood Purif; 2023; 52(4):366-372. PubMed ID: 36702111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.
    Aykut S; Caner C; Ozkan G; Ali C; Tugba A; Zeynep G; Taner C
    Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.
    Chu KH; Choy WY; Cheung CC; Fung KS; Tang HL; Lee W; Cheuk A; Yim KF; Chan WH; Tong KL
    Perit Dial Int; 2008; 28(5):505-8. PubMed ID: 18708544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.
    Pierce DA; Williamson JC; Mauck VS; Russell GB; Palavecino E; Burkart JM
    Perit Dial Int; 2012; 32(5):525-30. PubMed ID: 22302770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.
    Rodríguez-Carmona A; Pérez-Fontán M; López-Muñiz A; Ferreiro-Hermida T; García-Falcón T
    Perit Dial Int; 2014; 34(6):618-26. PubMed ID: 23818005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk factors of exit-site infection in incident peritoneal dialysis patients.
    Lin J; Ye H; Li J; Qiu Y; Wu H; Yi C; Lu S; Chen J; Mao H; Huang F; Yu X; Yang X
    Perit Dial Int; 2020 Mar; 40(2):164-170. PubMed ID: 32072873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
    Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
    Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study.
    Htay H; Choo JCJ; Johnson DW; Pascoe EM; Jayaballa M; Oei EL; Ng LC; Wu SY; Foo MWY
    Int Urol Nephrol; 2021 Apr; 53(4):803-812. PubMed ID: 33025409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
    Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP
    Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.
    van Esch S; Krediet RT; Struijk DG
    Perit Dial Int; 2014; 34(2):162-70. PubMed ID: 24584620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
    Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
    Davenport A;
    J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS; Sheth H; Piraino B; Bender F
    Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Local Polyhexanide Application in Preventing Exit-Site Infection and Peritonitis: A Randomized Controlled Trial.
    Ceri M; Yilmaz SR; Unverdi S; Kurultak I; Duranay M
    Ther Apher Dial; 2020 Feb; 24(1):81-84. PubMed ID: 31066988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between keeping home records of catheter exit-site and incidence of peritoneal dialysis-related infections.
    Iida H; Kurita N; Fujimoto S; Kamijo Y; Ishibashi Y; Fukuma S; Fukuhara S
    Int Urol Nephrol; 2018 Apr; 50(4):763-769. PubMed ID: 29349637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Aug; 20(8):1702-6. PubMed ID: 15855200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
    Cho KH; DO JY; Park JW; Yoon KW
    Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.
    Thodis E; Passadakis P; Ossareh S; Panagoutsos S; Vargemezis V; Oreopoulos DG
    Int J Artif Organs; 2003 Aug; 26(8):698-714. PubMed ID: 14521167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upward-directed exit-site of the swan-neck catheter and "Easy-to-disinfect the backside area of exit-site" may prevent PD complications.
    Ogawa K; Ikeda M; Shirai I; Ohshiro K; Maruyama Y; Yokoo T; Tanno Y; Terawaki H; Sakurada T; Yoshikawa K; Inoue H; Higuchi C; Kaneko T; Nogaki F; Ueda A; Maeda Y
    Clin Exp Nephrol; 2024 Jun; 28(6):547-556. PubMed ID: 38340245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.